Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

<p>Abstract</p> <p>Histone deacetylases (HDACs) can regulate expression of tumor suppressor genes and activities of transcriptional factors involved in both cancer initiation and progression through alteration of either DNA or the structural components of chromatin. Recently, the r...

Full description

Bibliographic Details
Main Authors:	Petrillo Richard L, Ma Yuehua, Cang Shundong, Tan Jiahuai, Liu Delong
Format:	Article
Language:	English
Published:	BMC 2010-02-01
Series:	Journal of Hematology & Oncology
Online Access:	http://www.jhoonline.org/content/3/1/5

Similar Items

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
by: Ma Yuehua, et al.
Published: (2009-06-01)

Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells
by: Shundong Cang, et al.
Published: (2016-01-01)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)

Clinical Toxicities of Histone Deacetylase Inhibitors
by: Richard L. Piekarz, et al.
Published: (2010-08-01)

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors
by: Qing-Yu Xu, et al.
Published: (2020-03-01)

The preclinical and clinical pharmacology of novel histone deacetylase inhibitors
by: Kristeleit, Rebecca Sophie
Published: (2008)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

Histone deacetylase inhibitors : mode of inhibition and histone deacetylase phosphorylation
by: Sekhavat, Anoushe
Published: (2013)

Histone deacetylase inhibitors : mode of inhibition and histone deacetylase phosphorylation
by: Sekhavat, Anoushe
Published: (2013)

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
by: Ververis K, et al.
Published: (2013-02-01)

Enhancing the anti-angiogenic action of histone deacetylase inhibitors
by: Dwarte Tanya, et al.
Published: (2007-10-01)

Histone Deacetylase Inhibitors for Selective Anti-Cancer Therapeutics
by: Choudhary, Shambhunath
Published: (2009)

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
by: Danqi Chen, et al.
Published: (2016-01-01)

Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
by: Madhusoodanan Mottamal, et al.
Published: (2015-03-01)

Anti-ovarian cancer effects of histone deacetylase inhibitors and calpain inhibitor
by: Lapinska, Karolina Eva
Published: (2016)

Synthesis of inhibitors of histone deacetylase
by: Dines, J.
Published: (2008)

Histone deacetylase inhibitors as novel neuroprotective agents in in vitro and in vivo models of Parkinson's disease
by: Page, Cecilia
Published: (2014)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Histone deacetylase inhibitors are effective therapeutic agents in nasopharyngeal carcinoma cells.
Published: (2006)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021-01-01)

Histone deacetylase inhibitors in multiple myeloma
by: Sarah Deleu, et al.
Published: (2009-06-01)

The application of histone deacetylases inhibitors in glioblastoma
by: Rui Chen, et al.
Published: (2020-07-01)

Histone Deacetylase Inhibitors as Anticancer Drugs
by: Tomas Eckschlager, et al.
Published: (2017-07-01)

Acetylation and Histone Deacetylase Inhibitors in Cancer
by: Madeleine S. Q. Kortenhorst, et al.
Published: (2006-01-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

Mechanistic analysis of histone deacetylase inhibitors
by: Fotheringham, Susan
Published: (2007)

Antidepressant Actions of Histone Deacetylase Inhibitors
by: Haggarty, Stephen J., et al.
Published: (2010)

The Effect of Novel Histone Deacetylase Inhibitor in Human Pancreatic Carcinoma
by: Wan-Yu Wu, et al.
Published: (2013)

The Molecular Mechanism of Histone Deacetylase (HDAC) Inhibitor PCI-24781 as an Anti-tumor Agent in Neuroblastoma Cells
Published: (2013)

Synthesis of prenyl transferase inhibitors and histone deacetylase inhibitors
by: Rioja, Alphonso Sid
Published: (2002)

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
by: Donya Naz Divsalar, et al.
Published: (2020-06-01)

The therapeutic role of histone deacetylase inhibitors in keloids
by: Kwan Yau Chan, et al.
Published: (2018)

Histone Deacetylase Inhibitors from Marine Invertebrates
by: Claudio Luparello, et al.
Published: (2020-11-01)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
by: Guo Li, et al.
Published: (2020-09-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies
by: H. Miles Prince, et al.
Published: (2010-08-01)

Attenuation of choroidal neovascularization by histone deacetylase inhibitor.
by: Nymph Chan, et al.
Published: (2015-01-01)

Zinc binding groups for histone deacetylase inhibitors
by: Lei Zhang, et al.
Published: (2018-01-01)

The effect of histone deacetylase inhibitors on AHSP expression.
by: Mohammad Ali Okhovat, et al.
Published: (2018-01-01)

Histone Deacetylase Inhibitors and Diabetic Kidney Disease
by: Mitchell J. Hadden, et al.
Published: (2018-09-01)